tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO

Northwest Biotherapeutics (NWBO) Revenue

Compare
539 Followers

Northwest Biotherapeutics Revenue

Northwest Biotherapeutics had a revenue of 200.00K in the quarter ending Sep 30, 2025, with 52.67%. This bring the company's revenue in the last twelve months to 937.00K, Increased -14.35%. In the fiscal year ending Dec 31, 2024, Northwest Biotherapeutics had annual revenue of 1.38M with -28.47% growth.
Revenue (ttm)
937.00K
Revenue Growth
P/S Ratio
237.46
Revenue/Employee
$55,280
Employees
25
Market Cap
$328.17M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.38M-550.00K-28.47%
Dec 31, 2023
1.93M249.00K+14.80%
Dec 31, 2022
1.68M678.00K+67.46%
Dec 31, 2021
1.00M-286.00K-22.15%
Dec 31, 2020
1.29M-1.12M-46.43%
Dec 31, 2019
2.41M2.00M+484.95%
Dec 31, 2018
412.00K76.00K+22.62%
Dec 31, 2017
336.00K